 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol
IDs
|
|
|
| |
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
|
|
|
|
Phase III
|
|
|
|
ECOG-E5202
E5202, NCT00217737
|
|
| |
Erlotinib in Treating Patients With Stage I, Stage II, or Stage III Colorectal Cancer or Adenoma
|
|
|
|
Phase II, Phase I
|
|
|
|
UCIRVINE-UCI06-8-01
UCI06-8-01, NCT00754494
|
|
| |
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
|
|
|
|
Phase II
|
|
|
|
CINJ-3330
NCT00161187
|
|
| |
Trial of Aspirin and Arginine Restriction in Colon Cancer
|
|
|
|
Phase II
|
|
|
|
UCI 07-47
NCT00578721
|
|
| |
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
|
|
|
|
Phase II
|
|
|
|
ETH190-06
ETH190-06, NCT00601198
|
|
| |
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
|
|
|
|
Phase I
|
|
|
|
CCUM-TASK2B
LRI-6930, N01-CN-25025-4, NCT00433576
|
|
| |
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
|
|
|
|
Phase I
|
|
|
|
06C.549
NCT00437372
|
|
| |
TRIAD Burden of Illness Mucositis Study
|
|
|
|
No phase specified
|
|
|
|
No. 200509024
NCT00336609
|
|
| |
Respiratory Tumor and Normal Tissue Motion
|
|
|
|
No phase specified
|
|
|
|
2003-0962
NCT00415675
|
|
| |
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
|
|
|
|
No phase specified
|
|
|
|
CCCWFU-99B98
CCCWFU 99B98, CCCWFU-BG99-047, NCT00489515
|
|
